» Articles » PMID: 15824350

Cognitive Change in ALS: a Prospective Study

Overview
Journal Neurology
Specialty Neurology
Date 2005 Apr 13
PMID 15824350
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate longitudinally the profile of cognitive impairment in nondemented patients with ALS.

Methods: Twenty nondemented patients with ALS and 18 controls were interviewed at two time points separated by a 6-month interval. The extensive battery was designed to accommodate the range of physical disability present in ALS, and included measures of executive, memory, language, and visuospatial functions, everyday behavior, and emotion.

Results: On a test of simple word retrieval (Computerised Sentence Completion Test) patients with ALS became slower over time, while controls became faster at completing sentences with appropriate words. This effect remained when the analysis accommodated for progressive speech disability. Patients with ALS also displayed an impairment in both written and spoken verbal fluency indices (time to think of each word) at both time points, but there was no evidence of deterioration over time. On the Short Inventory of Minor Lapses, carers of patients with ALS displayed increased awareness of cognitive dysfunction in everyday behavior while controls' ratings of their partners decreased. In addition, patients displayed more depressive symptomology (although well below clinical levels) on the second interview vs controls. Patients with ALS also displayed emotional lability at both time points, although this did not increase over time.

Conclusions: Cognitive deterioration in nondemented patients with ALS is a relatively slow process. Selective cognitive impairment in the form of verbal fluency deficits, most likely indicating executive dysfunction, appears relatively early on in the course of the disease, although language functions may become vulnerable as the disease progresses.

Citing Articles

Mild cognitive impairment in amyotrophic lateral sclerosis: current view.

Jellinger K J Neural Transm (Vienna). 2024; 132(3):357-368.

PMID: 39470847 DOI: 10.1007/s00702-024-02850-7.


Clinical, Cortical, Subcortical, and White Matter Features of Right Temporal Variant FTD.

Kleinerova J, McKenna M, Finnegan M, Tacheva A, Garcia-Gallardo A, Mohammed R Brain Sci. 2024; 14(8).

PMID: 39199498 PMC: 11352857. DOI: 10.3390/brainsci14080806.


Limbic Network and Papez Circuit Involvement in ALS: Imaging and Clinical Profiles in GGGGCC Hexanucleotide Carriers in and -Negative Patients.

Christidi F, Kleinerova J, Tan E, Delaney S, Tacheva A, Hengeveld J Biology (Basel). 2024; 13(7).

PMID: 39056697 PMC: 11273537. DOI: 10.3390/biology13070504.


Repeated cognitive assessments show stable function over time in patients with ALS.

Oijerstedt L, Foucher J, Lovik A, Yazdani S, Juto A, Klappe U J Neurol. 2024; 271(8):5267-5274.

PMID: 38853167 PMC: 11319384. DOI: 10.1007/s00415-024-12479-x.


The cortical neurophysiological signature of amyotrophic lateral sclerosis.

Trubshaw M, Gohil C, Yoganathan K, Kohl O, Edmond E, Proudfoot M Brain Commun. 2024; 6(3):fcae164.

PMID: 38779353 PMC: 11109820. DOI: 10.1093/braincomms/fcae164.